Cannabis stocks are having a rough go right now, with even some of the most profitable pot stocks taking a hit. So it’s probably not a surprise to learn that shares of one of the most promising clinical-stage cannabis companies, Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), have… Read More »Zynerba Pharmaceuticals Stock: This Pot Stock Has 715%+ Upside
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy. Many of the biggest public companies, especially the technology giants, trade in the… Read More »Goldman Sachs Has 5 Well-Known Buy-Rated Stocks Under $10 With Solid Upside Potential
The bear market boundary has been breached. With the Nasdaq Composite, the Nasdaq 100, the Russell 2000, and the S&P 500 (based on its May 20, 2022 intraday lows) are all 20% off their most recent all-time highs, many of my readers came to me… Read More »Here’s How To Spot The Market Bottom
With a market cap of just $80.1 million, Flora Growth Corp (NASDAQ:FLGC) is a small, overlooked pot stock. Don’t let its penny-stock status scare you away, though. FLGC stock is entrenched in penny-stock territory more because of the drawn-out process of legalizing marijuana at the U.S. federal… Read More »Flora Growth Stock: Under-The-Radar Pot Stock Has 500%+ Upside
At 24/7 Wall St., we know how important dividend size, stability, and growth are to growth and income investors that need a dependable stream of income. We often have written about the opportunities that the Dividend Aristocrats offer for long-term investors. These are the companies… Read More »The 7 Highest-Yielding Dividend Kings Likely Can Fight Inflation And A Recession
The current selling capitulation in the stock market reminds me of what happened in March 2020 when the COVID-19 pandemic locked down much of the world. The fact that a staggering 83% of Nasdaq stocks are trading below their 50-day and 200-day moving averages isn’t… Read More »Teradata Stock: Big Data Play To Benefit From $229-Billion Market
The market remains vulnerable to more downside simply because people who bought after the pandemic broke, investors who have impressive gains on paper, are treating the market like its Bitcoin circa 2013. That also means there is a persistent degree of volatility, and it doesn’t… Read More »The Bottom’s Not In Yet… Here’s How To Make Money While You Wait
Goldman Sachs on Thursday issued a report on several Buy-rated energy stocks the analysts continue to be bullish on, even though energy sector stocks have outperformed the S&P 500 by about 70% so far in 2022. Here is a look at five stocks in which… Read More »5 Energy Stocks Goldman Sachs Expects To Deliver More Than Dividends
The Nasdaq is down a stunning 28% from the 52-week high posted last November. There is a strong possibility that it could trade lower before all the carnage is complete. However, the comparisons to the dot-com bubble and explosion in 2000 are somewhat misguided, as… Read More »Jump On These 7 Tech Giants With Huge Dividends For Big Future Gains
Trulieve Cannabis Corp (CNSX:TRUL, OTCMKTS:TCNNF) is an excellent U.S. pot stock I’ve been following for a while now. Like the broader cannabis industry, TCNNF stock has been on a bit of a roller coaster ride. This volatility has more to do with what’s going on in… Read More »Trulieve Cannabis Corp: Undervalued Pot Stock Reports Record Q1 Results